Organogenesis Inc.
ORGO | NASDAQ
$1.48
+$0.08 (+5.71%)
Sep 22, 2026, 12:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 32.38 | -450.70 | 108.49 | 22.42 | 12.66 | 47.06 |
PEG Ratio | -0.01 | 3.79 | -1.58 | -0.27 | 0.04 | -0.35 |
PS Ratio | 1.17 | 0.87 | 1.24 | 0.78 | 2.54 | 2.40 |
PB Ratio | 1.51 | 1.09 | 1.93 | 1.32 | 4.91 | 5.72 |
P/FCF Ratio | -26.84 | 100.90 | 81.91 | -38.71 | 38.55 | -66.43 |
P/OCF Ratio | -63.68 | 29.66 | 17.36 | 14.07 | 19.13 | 148.42 |
OCF/S Ratio | -1.83 | 2.95 | 7.14 | 5.51 | 13.26 | 1.62 |
Debt / Equity Ratio | 0.31 | 0.11 | 0.43 | 0.47 | 0.55 | 0.60 |
Quick Ratio | 3.32 | 3.35 | 2.44 | 2.64 | 2.44 | 2.15 |
Current Ratio | 3.62 | 3.69 | 2.80 | 2.97 | 2.74 | 2.56 |
Asset Turnover | 0.94 | 0.97 | 0.94 | 1 | 1.05 | 1.17 |
Interest Coverage | n/a | -0.83 | 5.72 | 11.10 | 9.98 | 2.37 |
Return on Equity | 8.53% | 0.22% | 1.77% | 5.85% | 39.03% | 12.15% |
Return on Assets | 6.19% | 0.17% | 1.07% | 3.46% | 21.25% | 5.94% |
Return on Invested Capital | 8.52% | 0.09% | 1.49% | 4.37% | 19.25% | 10.69% |
Dividend Yield | n/a | 0.43% | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | 208.83% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | -28.09% | n/a | n/a | n/a | n/a |
Gross Profit Margin | 75.57% | 75.99% | 75.42% | 76.71% | 75.56% | 74.19% |
Net Profit Margin | 6.58% | 0.18% | 1.14% | 3.44% | 20.16% | 5.09% |
Pretax Profit Margin | 8.34% | -0.58% | 2.40% | 4.50% | 13.50% | 5.25% |
Operating Profit Margin | 9.92% | -0.27% | 2.89% | 4.95% | 15.45% | 7.89% |
FCF Margin | -4.34% | 0.87% | 1.51% | -2% | 6.58% | -3.61% |
EBITDA Margin | 13.13% | 3.27% | 8.32% | 8.94% | 18.61% | 11% |
Add to Watchlist
Select watchlists to add or remove ORGO